See What HealthDay Can Do For You
Contact Us

USPSTF: Screen Women for Chlamydia, Gonorrhea

Task Force cautions most women don't have symptoms from these infections

USPSTF: Screen Women for Chlamydia, Gonorrhea

TUESDAY, Sept. 23, 2014 (HealthDay News) -- All sexually active women should be screened for two of the most common sexually transmitted infections: chlamydia and gonorrhea, according to new recommendations from the U.S. Preventive Services Task Force. The final recommendation statement was published online Sept. 23 in the Annals of Internal Medicine.

The Task Force noted that this recommendation includes older women, those younger than 24 years of age, and pregnant women. Most women with chlamydia and gonorrhea don't develop noticeable symptoms. As a result, many infections go undetected. If left untreated, these sexually transmitted infections can cause serious complications for both women and unborn babies.

Although chlamydia and gonorrhea are most common among young women, older women who engage in risky sexual behaviors -- such as having multiple partners and not using condoms -- are also at risk, according to a news release from the American College of Physicians. If women develop new risk factors for these sexually transmitted infections since their last negative test result, they should be screened again. Pregnant women who test positive for chlamydia or gonorrhea in the first trimester should be re-tested three months after being treated.

There are no significant risks associated with screening for chlamydia and gonorrhea. The Task Force noted that there was not enough evidence to provide recommendations on chlamydia and gonorrhea screening for men.

Full Article
Evidence Review

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.